Filing Details
- Accession Number:
- 0001636282-24-000089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-08 16:53:52
- Reporting Period:
- 2024-11-06
- Accepted Time:
- 2024-11-08 16:53:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Spyre Therapeutics Inc. | SYRE | Pharmaceutical Preparations (2834) | 464312787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638474 | W. Jeffrey Albers | 221 Crescent Street, Building 23, Suite 105 Waltham MA 02453 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-06 | 6,700 | $36.76 | 27,360 | No | 4 | S | Indirect | By Sessions LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Sessions LLC |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2024.
- The price reported is a weighted average sale price of the Common Stock. These shares were sold in multiple transactions at prices ranging from $36.48 to $37.00, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
